Orchestra BioMed Holdings (OBIO) Payables (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has 7 years of Payables data on file, last reported at $6.3 million in Q1 2026.

• On a quarterly basis, Payables rose 13.48% year-over-year to $6.3 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 13.48% increase from a year earlier, with the FY2025 full-year figure at $6.1 million, up 18.72% from the prior year.
• Payables for Q1 2026 stood at $6.3 million, up from $6.1 million in the prior quarter.
• Over the last five years, Payables for OBIO reached as high as $8.5 million in Q3 2025 and fell as low as $103607.0 in Q1 2022.
• Historically, Payables has averaged $4.1 million across 5 years, with a median of $4.7 million in 2024.
• Across the five-year window, Payables jumped 16912.75% in 2022 and slumped 52.12% in 2023, its largest moves.
• Year by year, Payables stood at $6.1 million in 2022, then slumped by 52.12% to $2.9 million in 2023, then jumped by 77.03% to $5.1 million in 2024, then grew by 18.72% to $6.1 million in 2025, then increased by 3.58% to $6.3 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $6.3 million in Q1 2026, $6.1 million in Q4 2025, and $8.5 million in Q3 2025.